Cellaviva delivers stem cells to treat serious blood disease
NextCell Pharma AB ("NextCell" or the ”Company”) announces that the stem cell bank Cellaviva has released umbilical cord blood stem cells to Rigshospitalet, Denmark's leading hospital. A sibling of the child whose umbilical cord blood was stored in the Cellaviva biobank, suffers from a serious blood disorder which will be treated with stem cells at the Hematology Department of Rigshospitalet.Cord blood contains blood stem cells and is routinely used to treat severe diseases of the blood and immune system. The treatment is similar to bone marrow stem cell therapy and the most common use of